Episode 98: How to Navigate Biotech Innovation Amidst Government Funding Uncertainty
How can biotech companies stay resilient and competitive when public sector funding becomes unpredictable?
In this episode, host James Zanewicz, JD, LLM, RTTP, sits down with Adeyinka “Adey” Pierce-Watkins, MS, PMP—Director of Biodefense and Government Contracting at BDO USA—for a timely conversation on surviving and thriving in today’s evolving federal funding landscape. From defense contracts to international partnerships, Adey shares practical guidance for life science leaders aiming to tap into strategic public funding opportunities.
In this episode, you’ll learn:
- How to identify and access alternative funding sources—including state, federal, and international opportunities.
- What biotech organizations need in place to be “government-ready” for grants, contracts, and urgent response funding.
- Why strategic planning, partnerships, and compliance infrastructure are essential to winning and executing federal awards.
Whether you’re pursuing BARDA grants, entering international consortia, or rethinking your risk exposure, this episode offers actionable insights to help biotech innovators chart a smarter path forward.
Links:
Connect with Adey Pierce, MS, PMP, and check out BDO USA.
Connect with James Zanewicz, JD, LLM, RTTP, and learn about Tulane Medicine Business Development and the School of Medicine.
Learn more about the Cancer Prevention & Research Institute of Texas, TEDCO, and the California Institute for Regenerative Medicine.
Learn more about Flagship Pioneering, Andreessen Horowitz, Novartis, Johnson & Johnson, and Roche.
Learn more about HERA, Horizon Europe, AMED, and A*STAR.
Connect with Ian McLachlan, BIO from the BAYOU producer.
Check out BIO on the BAYOU and make plans to attend October 28 & 29, 2025.
Learn more about BIO from the BAYOU – the podcast.
Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.
